Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity
Authors
Keywords
Cancer-activated prodrug, Doxorubicin, Anticancer immune response, Immune suppressive effects, Immune checkpoint inhibitor
Journal
BIOMATERIALS
Volume 272, Issue -, Pages 120791
Publisher
Elsevier BV
Online
2021-04-02
DOI
10.1016/j.biomaterials.2021.120791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance
- (2020) Jinseong Kim et al. JOURNAL OF CONTROLLED RELEASE
- Enhancing anti-tumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
- (2019) K M Heinhuis et al. ANNALS OF ONCOLOGY
- Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer
- (2019) Wei Sun et al. BIOMATERIALS
- The potentiated checkpoint blockade immunotherapy by ROS-responsive nanocarrier-mediated cascade chemo-photodynamic therapy
- (2019) Liqin Hu et al. BIOMATERIALS
- Visible light-induced apoptosis activatable nanoparticles of photosensitizer-DEVD-anticancer drug conjugate for targeted cancer therapy
- (2019) Wooram Um et al. BIOMATERIALS
- Structural Polymorphism in a Self-Assembled Tri-Aromatic Peptide System
- (2018) Noam Brown et al. ACS Nano
- Nanoparticle-mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
- (2018) Xiaopin Duan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Combinational strategy for high-performance cancer chemotherapy
- (2018) Si-Yong Qin et al. BIOMATERIALS
- Carrier-free nanoparticles of cathepsin B-cleavable peptide-conjugated doxorubicin prodrug for cancer targeting therapy
- (2018) Man Kyu Shim et al. JOURNAL OF CONTROLLED RELEASE
- Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence Imaging
- (2016) Man Kyu Shim et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Inducing enhanced immunogenic cell death with nanocarrier-based drug delivery systems for pancreatic cancer therapy
- (2016) Xiao Zhao et al. BIOMATERIALS
- Doxorubicin-Induced Systemic Inflammation Is Driven by Upregulation of Toll-Like Receptor TLR4 and Endotoxin Leakage
- (2016) Lintao Wang et al. CANCER RESEARCH
- Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM
- (2016) D. Mathios et al. Science Translational Medicine
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Self-Assembly of Phenylalanine-Based Molecules
- (2014) Helen W. German et al. JOURNAL OF PHYSICAL CHEMISTRY A
- Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages
- (2014) Dagmar A Kuhn et al. Beilstein Journal of Nanotechnology
- TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
- (2013) Hongliang Fang et al. Cellular & Molecular Immunology
- Cathepsin B as a cancer target
- (2013) Christopher S Gondi et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Peptide-Mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Animal Models
- (2013) De-Kuan Chang et al. PLoS One
- Cathepsin B-cleavable doxorubicin prodrugs for targeted cancer therapy
- (2012) YAN-JUN ZHONG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting
- (2011) Tomáš Etrych et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester
- (2009) Michael Miksa et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
- Toll-like receptor-4 deficiency attenuates doxorubicin-induced cardiomyopathy in mice
- (2008) Alexander Riad et al. EUROPEAN JOURNAL OF HEART FAILURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started